Form 4 for PHVS Pharvaris N.V.
Accepted 2026-06-23 17:07:28 ET · period of report 2026-06-18 · accession 0001193125-26-279753 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-23 17:07 | 2026-06-18 | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $2.59 | +300 | 65.9K | +0.5% | +$777 |
| DT | 2026-06-23 17:07 | 2026-06-18 | PHVS | Lu Peng | Chief Medical Off | S - Sale+OE | $34.00 | -300 | 65.6K | -0.5% | -$10.2K |
| DT | 2026-06-23 17:07 | 2026-06-18 | PHVS | Lu Peng | Chief Medical Off | M - OptEx | $0.00 | -300 | 205.0K | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | M | A | 300 | $2.59 | 65,931 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 2 | Common | Common Stock | 2026-06-18 | S | D | 300 | $34.00 | 65,631 | D | — | — | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-06-18 | M | D | 300 | $0.00 | 205,008 | D | $2.59 · — to 2030-02-03 | 245,308 Common Stock | (F1) This is a scheduled exercise and sale from 10b5-1 trading plan. (F2) 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter. |